New data suggests the risk of blood clots from Astra-Zeneca is 1 in 60,000.
Ontario is going to pause first doses of the Oxford Astra-Zeneca vaccine over concerns around blood clots.
Chief Medical Officer of Health Dr. David Williams made the announcement during a press briefing this afternoon. New data suggests the risk of blood clots from Astra-Zeneca is higher then previously thought at 1 in 60,000.
This is not expected to impact the vaccine rollout in Ontario thanks to increased supply from Pfizer and Moderna.
The Province is currently reviewing data for second doses and it is possible those who got the first shot of Astra-Zeneca could end up with a second dose from Pfizer or Moderna. According to recent data, the risk of blood clots from the second dose of Astra-Zeneca is much smaller.
Dr. Williams did say anyone who already received the first dose of Astra-Zeneca did the right thing and this decision was made out of an abundance of caution. He notes the increased supply of Moderna and Pfizer helped make this an easier decision.

Death Investigation in Woodstock
MURC: Coming Soon to Ingersoll!
Candidate Information Session Coming Up
EZT Remembers Former Ward 3 Councillor
SWPH Issues Cold Weather Alert
UPDATE: Strong Winds Continue this Morning
Woodstock Resident Charged with Speeding
Interview with the Mayor - March 16th, 2026
Woodstock Driver Charged in Brant County
PJHL Playoff Recap - March 13th to March 15th
March Break Safety Tips from Oxford OPP
Oxford-Elgin Rainbow Research Project Underway
OPP: Plan Ahead Before St. Paddy's Day Festivities
Another Friday the 13th in Port Dover Today
Hansen Parents Visit Artemis II Explorers Club at IDCI
East Oxford Parents Respond to AARC Announcement
Strong Winds Expected in Oxford
WPS Charge Two in Firearms Incident
Food Rescue Hub Receives $50,000
Interview with the Warden - March 12th, 2026
Comments
Add a comment